First Time User? Enroll now.
Weather Updates: Check our weather closings and delays page to see if your facility or clinic is impacted by inclement weather.COVID-19: Vaccine information, visitor restrictions, testing, treatment, and additional resources | Medicaid: The program is changing and you must take steps to keep your UNC Health providers
Home > Health Library > Cell-Free DNA Test
Cell-free fetal DNA is a screening test to look for certain birth defects in a fetus. It's done to find birth defects caused by an abnormal number of chromosomes. It also can reveal the sex and blood type of the fetus.
This is a blood test for the mother. The test can be done as early as 10 weeks in the pregnancy.
If this screening test is positive, it means there is a chance your baby has a birth defect. In that case, your doctor may suggest that you have a diagnostic test, which can show if there is a birth defect.
Health Tools help you make wise health decisions or take action to improve your health.
The test is used to look for birth defects caused by too many or too few chromosomes, such as trisomy 18 and Down syndrome (trisomy 21).
In general, there's nothing you have to do before this test, unless your doctor tells you to.
A health professional uses a needle to take a blood sample, usually from the arm.
When a blood sample is taken, you may feel nothing at all from the needle. Or you might feel a quick sting or pinch.
There is very little chance of having a problem from this test. When a blood sample is taken, a small bruise may form at the site.
The fetal DNA will be looked at to see if there are missing or extra chromosomes. If there is an extra or missing chromosome (a positive result), your baby may have a chromosomal birth defect. A negative result means that your baby is unlikely to have one of the birth defects this test looks for.
This test can find up to 99% of trisomies such as 18 and 21. That means that it will find these birth defects up to 99 times out of 100 and won't find them 1 time out of 100.footnote 1
American College of Obstetricians and Gynecologists (2016). Screening for fetal aneuploidy. ACOG Practice Bulletin No. 163. Obstetrics and Gynecology, 127(5): e123–e137. DOI: 10.1097/AOG.0000000000001406. Accessed April 6, 2017.
Current as of:
June 16, 2021
Author: Healthwise StaffMedical Review: Kathleen Romito MD - Family MedicineE. Gregory Thompson MD - Internal MedicineAdam Husney MD - Family MedicineSiobhan M. Dolan MD, MPH - Reproductive Genetics
Current as of: June 16, 2021
Author: Healthwise Staff
Medical Review:Kathleen Romito MD - Family Medicine & E. Gregory Thompson MD - Internal Medicine & Adam Husney MD - Family Medicine & Siobhan M. Dolan MD, MPH - Reproductive Genetics
To learn more about Healthwise, visit Healthwise.org.
© 1995-2021 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
2615 Lake Drive
Raleigh, NC 27607
901 Ridgefield Drive
Raleigh, NC 27609
934 Vandora Springs Road
Garner, NC 27529
781 Avent Ferry Road
REX Healthcare of Holly Springs, Suite 106
Holly Springs, NC 27540
4414 Lake Boone Trail
Raleigh, NC 27607